Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus

Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus

Abstract Background Platelets in patients with type 2 diabetes mellitus (DM2) are characterized by increased activation and aggregation, which tends to be associated with a high morbidity and mortality due to cardiovascular disease (CVD). Moreover, a large proportion of DM2 patients show an inadequa...

Full description

Bibliographic Details
Main Authors: Ai-ming Zhou, Yi-jia Xiang, En-qian Liu, Chang-hong Cai, Yong-hui Wu, Le-bing Yang, Chun-lai Zeng
Format: Article
Language:English
Published: BMC 2020-01-01
Series:BMC Cardiovascular Disorders
Subjects:
Type 2 diabetes mellitus
Salvianolic acid a
PAC-1
CD62p
Maximal platelet aggregation
Online Access:https://doi.org/10.1186/s12872-019-01316-z

Similar Items

Similar Items